Sea cucumber protein used to inhibit development of malaria parasiteDecember 27, 2007Scientists have genetically engineered a mosquito to release a sea-cucumber protein into its gut which impairs the development of malaria parasites, according to research out today (21 December) in PLoS Pathogens. Researchers say this development is a step towards developing future methods of preventing the transmission of malaria. Malaria is caused by parasites whose lives begin in the bodies of mosquitoes. When mosquitoes feed on the blood of an infected human, the malaria parasites undergo complex development in the insect's gut. The new study has focused on disrupting this growth and development with a lethal protein, CEL-III, found in sea cucumbers, to prevent the mosquito from passing on the parasite. Human blood infected with malaria contains parasitic gametocytes - cells which can create parasite sperm and eggs in the gut of the insect. These then fertilise, kick-starting the parasite reproductive process and life cycle by producing invasive offspring called ookinetes. These ookinetes then migrate through the mosquito's stomach wall and produce thousands of 'daughter' cells known as sporozoites. After 10-20 days these are ready in the salivary glands to infect another human when the mosquito takes a subsequent blood meal. The international team fused part of the sea cucumber lectin gene with part of a mosquito gene so that the mosquito would release lectin into its gut during feeding. The released lectin is toxic to the ookinete and therefore kills the parasite in the mosquito's stomach. In laboratory tests the research team showed that introducing lectin to the mosquito's gut in this way significantly impaired the development of malaria parasites inside the mosquito, potentially preventing transmission to other people. Early indications suggest that this sea cucumber protein could be effective on more than one of the four different parasites that can cause malaria in humans. Professor Bob Sinden from Imperial College London's Department of Life Sciences, one of the authors on the paper said: "These results are very promising and show that genetically engineering mosquitoes in this way has a clear impact on the parasites' ability to multiply inside the mosquito host." However, Professor Sinden explains that there is still a lot of work to do before such techniques can be used to combat the spread of malaria in real-world scenario. This is because although the sea cucumber protein significantly reduces the number of parasites in mosquitoes, it does not totally remove all parasites from all mosquitoes and as such, at this stage of development, would not be effective enough to prevent transmission of malaria to humans. Professor Sinden says he hopes studies such as this one, which improve scientists' understanding of the complex process by which malaria parasites are transmitted, will lead to new advances in the quest to prevent malaria. "Ultimately, one aim of our field is to find a way of genetically engineering mosquitoes so that the malaria parasite cannot develop inside them. This study is one more step along the road towards achieving that goal, not least because it has been shown that more than one species of malaria can be killed in this way." About 40% of the world's population are at risk of malaria. Of these 2.5 billion people at risk, more than 500 million become severely ill with malaria every year and more than 1 million die from the effects of the disease. Malaria is especially a serious problem in Africa, where one in every five childhood deaths is due to the effects of the disease. An African child has on average between 1.6 and 5.4 episodes of malaria fever each year. Public Library of Science |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||